Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
Patent 5753228 Issued on May 19, 1998. Estimated Expiration Date: 
May 19, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
May 19, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMarek's disease vaccine Vaccine against Newcastle fowl disease, method for preparing and use thereof Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells Recovering purified antibodies from egg yolk Oral immune globulin Manufacture and use of fowl egg antibodies Method of passive immunization of mammals using avian antibody Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus Avian immunoglobulin-producing cell lines Chicken-derived immunoglobulin-producing cell lines InventorsApplicationNo. 349840 filed on 12/05/1994US Classes:424/151.1, Binds parasitic organism (i.e., parasitic protozoan, multicellular ectoparasite (e.g., flea, tick, mite, etc.), or multicellular endoparasite (e.g., parasitic worm, etc.)) or component thereof or substance produced by said parasitic organism424/130.1, IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL530/387.1, Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed530/388.6Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell-surface antigen, etc.)ExaminersPrimary: Eisenschenk, Frank C.Assistant: Nolan, Patrick J. Attorney, Agent or FirmInternational ClassesA61K 039/395C07K 016/00 C12P 021/08 AbstractEgg yolks and egg yolk fractions containing effective therapeutic concentrations of avian antibodies against parasitic antigen, and a method of providing passive immunization for the prevention or treatment of intestinal parasitosis by enteral administration of egg yolk antibodies harvested from hyperimmunized avian hens. Also provided are pharmaceutical formulations comprising the egg yolk antibodies.Other References
Field of SearchIMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIALBinds bacterium or component thereof or substance produced by said bacterium Reduced antigenicity, reduced ability to bind complement, or reduced numbers of activated complement components (e.g., free from aggregated, denatured, fragmented, or polymerized immunoglobulins; free from proteolytic enzymes, etc.) Binds parasitic organism (i.e., parasitic protozoan, multicellular ectoparasite (e.g., flea, tick, mite, etc.), or multicellular endoparasite (e.g., parasitic worm, etc.)) or component thereof or substance produced by said parasitic organism Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed Binds parasitic protozoan or metazoan cell or component or product thereof (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell-surface antigen, etc.) Polyclonal antibody or immunogloblin of identified binding specificity Binds bacterium or similar microorganism or component or product thereof (e.g., Pseudomonas, Chlamydia, Clostridium, bacterium-associated antigen, etc.) |
| ||||||||||||||
